These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24037457)

  • 1. A comparative DFT study on aquation and nucleobase binding of ruthenium (II) and osmium (II) arene complexes.
    Wang H; Zeng X; Zhou R; Zhao C
    J Mol Model; 2013 Nov; 19(11):4849-56. PubMed ID: 24037457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amide linkage isomerism as an activity switch for organometallic osmium and ruthenium anticancer complexes.
    van Rijt SH; Hebden AJ; Amaresekera T; Deeth RJ; Clarkson GJ; Parsons S; McGowan PC; Sadler PJ
    J Med Chem; 2009 Dec; 52(23):7753-64. PubMed ID: 19791745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organometallic ruthenium(II) diamine anticancer complexes: arene-nucleobase stacking and stereospecific hydrogen-bonding in guanine adducts.
    Chen H; Parkinson JA; Parsons S; Coxall RA; Gould RO; Sadler PJ
    J Am Chem Soc; 2002 Mar; 124(12):3064-82. PubMed ID: 11902898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organometallic osmium(II) arene anticancer complexes containing picolinate derivatives.
    van Rijt SH; Peacock AF; Johnstone RD; Parsons S; Sadler PJ
    Inorg Chem; 2009 Feb; 48(4):1753-62. PubMed ID: 19146436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions.
    Peacock AF; Habtemariam A; Fernández R; Walland V; Fabbiani FP; Parsons S; Aird RE; Jodrell DI; Sadler PJ
    J Am Chem Soc; 2006 Feb; 128(5):1739-48. PubMed ID: 16448150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bipyrimidine ruthenium(II) arene complexes: structure, reactivity and cytotoxicity.
    Betanzos-Lara S; Novakova O; Deeth RJ; Pizarro AM; Clarkson GJ; Liskova B; Brabec V; Sadler PJ; Habtemariam A
    J Biol Inorg Chem; 2012 Oct; 17(7):1033-51. PubMed ID: 22791215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuning the hydrolytic aqueous chemistry of osmium arene complexes with N,O-chelating ligands to achieve cancer cell cytotoxicity.
    Peacock AF; Parsons S; Sadler PJ
    J Am Chem Soc; 2007 Mar; 129(11):3348-57. PubMed ID: 17319668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of the "piano-stool" [ruthenium(II) (eta6-arene)(en)CL]+ complexes with water and nucleobases; ab initio and DFT study.
    Futera Z; Klenko J; Sponer JE; Sponer J; Burda JV
    J Comput Chem; 2009 Sep; 30(12):1758-70. PubMed ID: 19090568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metal complexes as DNA intercalators.
    Liu HK; Sadler PJ
    Acc Chem Res; 2011 May; 44(5):349-59. PubMed ID: 21446672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electronic structures of ruthenium and osmium complexes of 9,10-phenanthrenequinone.
    Biswas MK; Patra SC; Maity AN; Ke SC; Adhikary ND; Ghosh P
    Inorg Chem; 2012 Jun; 51(12):6687-99. PubMed ID: 22663598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly selective binding of organometallic ruthenium ethylenediamine complexes to nucleic acids: novel recognition mechanisms.
    Chen H; Parkinson JA; Morris RE; Sadler PJ
    J Am Chem Soc; 2003 Jan; 125(1):173-86. PubMed ID: 12515520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derivation of structure-activity relationships from the anticancer properties of ruthenium(II) arene complexes with 2-aryldiazole ligands.
    Martínez-Alonso M; Busto N; Jalón FA; Manzano BR; Leal JM; Rodríguez AM; García B; Espino G
    Inorg Chem; 2014 Oct; 53(20):11274-88. PubMed ID: 25302401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlorido-, aqua-, 9-ethylguanine- and 9-ethyladenine-adducts of cytotoxic ruthenium arene complexes containing O,O-chelating ligands.
    Melchart M; Habtemariam A; Parsons S; Sadler PJ
    J Inorg Biochem; 2007 Nov; 101(11-12):1903-12. PubMed ID: 17582501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantum Chemical Investigation on Hydrolysis of Orally Active Organometallic Ruthenium(II) and Osmium(II) Anticancer Drugs and Their Interaction with Histidine.
    Pradhan AK; Shyam A; Dutta A; Mondal P
    J Phys Chem B; 2022 Nov; 126(46):9516-9527. PubMed ID: 36378950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism elucidation of the cis-trans isomerization of an azole ruthenium-nitrosyl complex and its osmium counterpart.
    Gavriluta A; Büchel GE; Freitag L; Novitchi G; Tommasino JB; Jeanneau E; Kuhn PS; González L; Arion VB; Luneau D
    Inorg Chem; 2013 Jun; 52(11):6260-72. PubMed ID: 23675748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the reactivity of organometallic Ru-, Rh- and Os-pta complexes with DNA model compounds.
    Dorcier A; Hartinger CG; Scopelliti R; Fish RH; Keppler BK; Dyson PJ
    J Inorg Biochem; 2008; 102(5-6):1066-76. PubMed ID: 18086499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monometallic osmium(II) complexes with bis(N-methylbenzimidazolyl)benzene or -pyridine: a comparison study with ruthenium(II) analogues.
    Shao JY; Zhong YW
    Inorg Chem; 2013 Jun; 52(11):6464-72. PubMed ID: 23688019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homo- and Hetero-dinuclear Arene-Linked Osmium(II) and Ruthenium(II) Organometallics: Probing the Impact of Metal Variation on Reactivity and Biological Activity.
    Wilson CS; Prior TJ; Sandland J; Savoie H; Boyle RW; Murray BS
    Chemistry; 2020 Sep; 26(50):11593-11603. PubMed ID: 32520396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodissociation of a ruthenium(II) arene complex and its subsequent interactions with biomolecules: a density functional theory study.
    Wang H; DeYonker NJ; Zhang X; Zhao C; Ji L; Mao ZW
    J Mol Model; 2012 Oct; 18(10):4675-86. PubMed ID: 22653608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships for organometallic osmium arene phenylazopyridine complexes with potent anticancer activity.
    Fu Y; Habtemariam A; Basri AM; Braddick D; Clarkson GJ; Sadler PJ
    Dalton Trans; 2011 Oct; 40(40):10553-62. PubMed ID: 21860862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.